H.R. 6485 · 119th Congress (2025–2027)
Skinny Labels, Big Savings Act
This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.
Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics.
The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act:
- submitting or seeking approval of a skinny label for a generic or biosimilar drug;
- promoting or commercially marketing a drug with skinny labeling approved by the FDA; or
- describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug.
The bill also applies the safe harbor to similar actions under the Public Health Service Act.
Show official title
To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 6485’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Ben Cline (R-VA-6)
- Cosponsors
6 cosponsors
1 original · 5 later
3 R · 3 D
- Rep. Zoe Lofgren (D-CA-18)· Original · Dec 5, 2025
- Rep. Jennifer A. Kiggans (R-VA-2)· Later · Apr 20, 2026
- Rep. Thomas R. Suozzi (D-NY-3)· Later · Apr 20, 2026
- Rep. August Pfluger (R-TX-11)· Later · May 19, 2026
- Rep. Glenn Grothman (R-WI-6)· Later · Jun 15, 2026
- Rep. Angie Craig (D-MN-2)· Later · Jun 23, 2026
- Policy area
- Commerce
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on the Judiciary.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Skinny Labels, Big Savings Act
Display title, Short title · Introduced in House
To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
Official title · Introduced in House